|
| 30918988 | Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement. | Eur J Clin Pharmacol | 2019 |
| 31254013 | Correction to: Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement. | Eur J Clin Pharmacol | 2019 |
| 29310768 | SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation. | J Allergy Clin Immunol Pract | 2018 |
| 35135159 | Use of Next-Generation Sequencing Tests to Guide Cancer Treatment: Results From a Nationally Representative Survey of Oncologists in the United States. | JCO Precis Oncol | 2018 |
| 28296986 | Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working Group. | JAMA Dermatol | 2017 |
| 24845428 | Meeting research needs with postmortem biospecimen donation: summary of recommendations for postmortem recovery of normal human biospecimens for research. | Biopreserv Biobank | 2013 |
| 20458532 | No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive families. | Breast Cancer Res Treat | 2011 |
| 21269473 | The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. | BMC Med Genomics | 2011 |
| 20332101 | Fine scale mapping of the breast cancer 16q12 locus. | Hum Mol Genet | 2010 |
| 19214745 | Polymorphisms in estrogen biosynthesis and metabolism-related genes, ionizing radiation exposure, and risk of breast cancer among US radiologic technologists. | Breast Cancer Res Treat | 2009 |
| 19138047 | Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. | Radiat Res | 2009 |
| 19126777 | Association of ESR1 gene tagging SNPs with breast cancer risk. | Hum Mol Genet | 2009 |
| 19223389 | FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. | Hum Mol Genet | 2009 |
| 19277124 | Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma. | PLoS One | 2009 |
| 17764108 | Polymorphisms in DNA repair genes, ionizing radiation exposure and risk of breast cancer in U.S. Radiologic technologists. | Int J Cancer | 2008 |
| 18708391 | Breast cancer risk polymorphisms and interaction with ionizing radiation among U.S. radiologic technologists. | Cancer Epidemiol Biomarkers Prev | 2008 |
| 18251999 | Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping. | BMC Genet | 2008 |
| 18437204 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. | PLoS Genet | 2008 |
| 18158280 | Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999. | Eur J Med Genet | 2008 |
| 17220349 | Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes: a nested case-control study within a cohort of U.S. radiologic technologists. | Cancer Epidemiol Biomarkers Prev | 2007 |
| 17999359 | RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. | Am J Hum Genet | 2007 |
| 17932347 | Polymorphisms in apoptosis- and proliferation-related genes, ionizing radiation exposure, and risk of breast cancer among U.S. Radiologic Technologists. | Cancer Epidemiol Biomarkers Prev | 2007 |
| 17916242 | The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies. | BMC Genet | 2007 |
| 17627006 | AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. | Cancer Epidemiol Biomarkers Prev | 2007 |
| 17529967 | Genome-wide association study identifies novel breast cancer susceptibility loci. | Nature | 2007 |
| 17525135 | Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench (CGWB). | Genome Res | 2007 |
| 17293864 | A common coding variant in CASP8 is associated with breast cancer risk. | Nat Genet | 2007 |
| 15923273 | Skewed X chromosome inactivation and early-onset breast cancer. | J Med Genet | 2006 |
| 16969872 | BRCA1/2 testing in hereditary breast and ovarian cancer families III: risk perception and screening. | Am J Med Genet A | 2006 |
| 16966163 | Quantitation of DNA in buccal cell samples collected in epidemiological studies. | Biomarkers | 2006 |
| 16923772 | Candidate single nucleotide polymorphism selection using publicly available tools: a guide for epidemiologists. | Am J Epidemiol | 2006 |
| 16485136 | Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. | Hum Genet | 2006 |
| 16434590 | The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. | Cancer Epidemiol Biomarkers Prev | 2006 |
| 16652348 | The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer. | Hum Mutat | 2006 |
| 16206141 | Localization of breast cancer susceptibility loci by genome-wide SNP linkage disequilibrium mapping. | Genet Epidemiol | 2006 |
| 15633195 | BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships. | Am J Med Genet A | 2005 |
| 16314625 | Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. | J Clin Oncol | 2005 |
| 16099702 | DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individuals. | Mutat Res | 2005 |
| 15113441 | Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. | BMC Cancer | 2004 |
| 15529312 | Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study. | Cancer | 2004 |
| 15622558 | Breast cancer risks for BRCA1/2 carriers. | Science | 2004 |
| 15687692 | Genomic approaches to identifying breast cancer susceptibility factors. | Breast Dis | 2004 |
| 15173226 | Prospective risk of cancer in CDKN2A germline mutation carriers. | J Med Genet | 2004 |
| 15378542 | BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention. | Am J Med Genet A | 2004 |
| 15382084 | CHEK2:1100delC and female breast cancer in the United States. | Int J Cancer | 2004 |
| 14735199 | XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk. | Br J Cancer | 2004 |
| 15114373 | BRCA1 and sex ratio. | Eur J Hum Genet | 2004 |
| 12504628 | Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women. | Gynecol Oncol | 2003 |
| 12928354 | Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. | J Natl Cancer Inst | 2003 |
| 12872252 | Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals. | Hum Mutat | 2003 |